Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Disentangling extrachromosomal circular DNA heterogeneity in single cells with scEC&T-seq

We introduce scEC&T-seq, a new single-cell sequencing method that enables parallel profiling of extrachromosomal circular DNA and mRNAs in single cells. Using scEC&T-seq, we characterized all types of circular DNA elements in single human cancer cells and profiled the intercellular heterogeneity and structural dynamics of cancer-specific extrachromosomal DNA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: scEC&T-seq enables parallel detection of circular DNA and transcriptome in single cells.

References

  1. Yi, E., Chamorro González, R., Henssen, A. G. & Verhaak, R. G. W. Extrachromosomal DNA amplifications in cancer. Nat. Rev. Genet. 23, 760–771 (2022). This review article summarizes the genetic and epigenetic features of ecDNA and how they influence oncogene deregulation.

    Article  CAS  PubMed  Google Scholar 

  2. Noer, J. B., Hørsdal, O. K., Xiang, X., Luo, Y. & Regenberg, B. Extrachromosomal circular DNA in cancer: history, current knowledge, and methods. Trends Genet. 38, 766–781 (2022). This review summarizes the nomenclature of extrachromosomal circular DNAs.

    Article  CAS  PubMed  Google Scholar 

  3. Lange, J. T. et al. The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat. Genet. 54, 1527–1533 (2022). This article describes how ecDNA is segregated to daughter cells and how this segregation affects inter-cellular ecDNA copy number heterogeneity as well as treatment response.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kim, H. et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat. Genet. 52, 891–897 (2020). This paper presents the first pan-cancer analysis of ecDNA amplification across cancer types and reveals that ecDNA is common in cancer and associated with poor outcome.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Møller, H. D., Parsons, L., Jørgensen, T. S., Botstein, D. & Regenberg, B. Extrachromosomal circular DNA is common in yeast. Proc. Natl Acad. Sci. USA 112, E3114–E3122 (2015). This paper describes the Circle-seq method.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Koche, R. P. et al. Extrachromosomal circular DNA drives oncogenic genome remodelling in neuroblastoma. Nat. Genet. 52, 29–34 (2020). This work is the first to use circular DNA sequencing to describe ecDNA in neuroblastoma samples and reveals how ecDNA affects genome organization.

    Article  CAS  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: González, R. C. et al. Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells. Nat. Genet. https://doi.org/10.1038/s41588-023-01386-y (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Disentangling extrachromosomal circular DNA heterogeneity in single cells with scEC&T-seq. Nat Genet 55, 740–741 (2023). https://doi.org/10.1038/s41588-023-01385-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-023-01385-z

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research